Last Updated on August 31, 2022
Introduction / Pathophysiology
• Infant of diabetic mother: related to neonatal hyperinsulinism
• SGA / Preterm infant: related to glycogen storage
• Implications of hypoglycaemia: may cause permanent neurologic injury
Definition & Target Plasma Glucose Level
Definition:
• Hypoglycaemia: Plasma glucose concentration low enough to cause symptoms and/or signs of impaired brain function
• Persistent Hypoglycaemia: Failure to maintain normal blood glucose despite glucose delivery >8 – 10 mg/kg/min
• Recurrent / Resistant Hypoglycaemia: Failure to maintain normal blood glucose despite glucose delivery >15 mg/kg/min
Types:
• Transitional hypoglycaemia
• Persistent hypoglycaemia / Onset first time beyond day 3 of life
Accepted range:
• < 4 hours of life: >1.5 mmol/L (provided infant is well, asymptomatic, tolerating feeds and repeat blood glucose is >2.6 mmol/L)
• <48 hours of life: >2.6 mmol/L
• >48 hours of life: >3.3 mmol/L
Risk of neonatal hypoglycaemia
Increased Risk | High Risk |
• Infant of diabetic mother (GDM / DM) on diet or OHA with good glycaemic control • Late preterm 35 – 366/7 weeks • SGA / LGA / low birth weight 1800 – 2500 g • Maternal obesity BMI >30 kg/m2 OR weight >80 at last visit | • Infant of diabetic mother on insulin (GDM / DM) / with poorly controlled sugar (HbA1c >6.5%) • Preterm 34 – 346/7 weeks • Birth weight <1800 g // >4000 g |
Other risks:
• Perinatal stress
• birth asphyxia / ischaemia; Caesarean delivery for fetal distress
• Maternal pre-eclampsia / eclapmsia / hypertension
• IUGR
• Meconium aspiration syndrome
• Polycythaemia
• hypothermia
Signs
• Jitteriness / Seizures
• Irritability
• Poor feeding
• Hypothermia
• Lethargy
• Apnoea / Cyanotic episodes
• Hypotonia
• High pitched cry
Characteristic | Jitteriness | Seizure |
Can external stimulus initiate? | Yes | No |
Movements | Symmetrical fine tremors | Irregular & jerky |
Associated with ↑ heart rate | No | Yes |
Associated with apnoea | No | ± |
Can movements be easily stopped? | Yes. Gently bending / holding limb // making the baby suck | No. Self-limited movements |
Management – Monitoring
If Dxt consistently ≥2.6 mmol/L
• LGA infant & infant of diabetic mother: monitor dxt till 12 hours of life
→ Increased risk: monitored in postnatal ward
→ High risk: monitored in NICU for first 6 hours of life, then continue in postnatal ward
• SGA & preterm infants: monitor dxt till 24 hours of life
→ Increased risk: monitored in postnatal ward
→ High risk: monitored in NICU until 12 hours of life, then continue in postnatal ward
Any Dxt <2.6 mmol/L
• Monitor dxt for additional 24 hours until stable
Note: Duration & frequency of monitoring may be different in different center
Management – Hypoglycaemia
First 4 hours of life + Blood glucose <1.5 // symptomatic
• IV Dextrose 10% 2 – 3 mL/kg bolus, then
• IVI Dextrose 10% 60 – 90 mL/kg/day
• If infant already on IVI Dextrose 10%, consider increasing IVI rate / glucose concentration (usually require 6 – 8 mg/kg/min glucose delivery)
First 4 hours of life + Blood glucose 1.5 – 2.5 AND asymptomatic
• Supplementary feed (EBM / formula) as soon as possible
• Re-check Dxt in 1 hour post-feeding
• If blood glucose remains <2.6 mmol/L and infant refused feeds, start IV Dextrose 10% drip
• If infant already on IVI Dextrose 10%, consider stepwise increment of glucose infusion rate by 2 mg/kg/min until blood glucose >2.6 mmol/L
======
Glucose monitoring post-hypoglycaemia
• If below target level, re-check glucose every 30 mins
• If blood glucose level above target x2, then monitor hourlyx2, then 2 hourly x2, then 3 – 6 hourly pre-feeding
Feeding & Dextrose IV drip
• Increase feeding as tolerated
• Reduce IVI Dextrose 10% 1 hour after feeding increment
Persistent Hypoglycaemia
• Hypoglycaemia persisting >48 HOL // First time after 48 HOL are likely due to:
→ Infection
→ metabolic / endocrine disorders
• Ensure patency of vascular access !!!
• Send random blood sugar and critical sampling before correction of hypoglycaemia
• REFER tertiary center for treatment options e.g. SC Octreotide, IV Hydrocortisone, IM/SC/IV Glucagon etc.
Others
References
1. Paediatric Protocol 4th Ed
2. Screening and management of neonatal hypoglycaemia, Neonatal Unit HTA 2019